Nusinersen: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nusinersen. Educational only — not medical advice.
Labeled uses
SPINRAZA is indicated for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients.
Source: FDA labeling via NIH DailyMed (set dd70cd5f…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.